The Best Way to Win? Don’t Lose — A Low-Volatility Biotech Buy
The volatility factor helps you avoid the worst stock losers. This biotech company’s low volatility is a bonus as well.
Posted by Adam O'Dell | Jun 21, 2021 | Investing
The volatility factor helps you avoid the worst stock losers. This biotech company’s low volatility is a bonus as well.
Posted by Adam O'Dell | Jun 17, 2021 | Investing
You might think the entire biotech market segment carries more risk than, say, all consumer staples. Stock volatility may reveal an answer.
Posted by Adam O'Dell | Jun 15, 2021 | Investing
If you are looking for an inflation hedge, these three commodity ETFs are a safe bet.
Posted by Adam O'Dell | Jun 10, 2021 | Investing
We are heading into a commodities bull market. Supply and demand are not at equilibrium, and commodity prices will head higher until they are.
Posted by Adam O'Dell | Jun 7, 2021 | Investing
Venture capitalist Chamath Palihapitiya recently announced plans for four DNA SPACs, and that’s a huge deal for genomics stocks going forward.
In his free newsletter, What My System Says Today, Adam O’Dell uses his Green Zone Power Rating system to keep you in the know and focused on the market’s best (and worst) opportunities. It’s a data-driven approach underpinned by Wall Street-caliber tools you can only get here at Money & Markets. Sign up for FREE access to our daily emails now!
Enter your username and password below